Indeed, ablation of TRAF3 in the mouse or reduced TRAF3 levels in myeloma [12], [13] and HSE patients [18] elevate NIK expression resulting in constitutive activation of the NF-κB2 pathway and accumulation of transcriptionally active p52. The gene discussed is NFKB2; the disease is plasma cell myeloma.